Guided Therapeutics Inc (OTCBB:GTHP) Boosted By News

[[tagnumber 0]][[tagnumber 1]]Last month Guided Therapeutics Inc (OTCBB:GTHP) experienced the consequences of negative news regarding FDA approvals. Back then it was announced that the company’s pre–market approval application for the LuViva® Advanced Cervical Scan was “not approvable in its current form”.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This led to a serious drop of 30% over the course of a single intense session in which [[tagnumber 6]]GTHP’s [[tagnumber 7]]volume was the highest for the past five years. That was to be expected, especially when you consider the fact that the company’s latest financial report wasn’t very enthusing. Here is what its balance sheet contained.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $18 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $1.57 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $5.16 million[[tagnumber 13]] [[tagnumber 12]]quarterly revenues: $127 thousand[[tagnumber 13]] [[tagnumber 12]]quarterly net loss: $1.24 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]As expected, the company continued to struggle after the big drop and even went below the 10 cent mark in the final days of last month. More recently it managed to somewhat stabilize at said mark even without the use of press releases.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Before yesterday’s market open, however, the company issued a PR which announced that the company has received an order for 100 LuViva® devices and 100 thousand single–use Cervical Guides from the Turkish Ministry of Health, through its distribution partner in the country, ITEM Medical Technologies.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]It wasn’t surprising that [[tagnumber 6]]GTHP [[tagnumber 7]]started climbing the charts from the beginning of the session. By the end the ticker had managed to gain a total of 40% in value and closed at $0.14. The volume was more than three times the average with some 1.72 million shares changing hands, generating $221 thousand in daily trade value.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Today we will see if there are more gains to be squeezed out of the press release. In any case, be sure to do your due diligence and weigh out the risks before putting any money on the line. [[tagnumber 2]]